<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-116331</identifier>
<setSpec>0210-0010</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Adaptation and validation of CAMDEX-DS (Cambridge Examination for Mental Disorders of Older People with Down&#146;s Syndrome and Others with Intellectual Disabilities) in Spanish population with intellectual disabilities</dc:title>
<dc:description xml:lang="en">Introduction. Dementia caused by Alzheimer&#146;s disease commonly affects the adult population with Down&#146;s syndrome. This population presents two characteristic clinical features: a semiologic pattern that differs from the typical Alzheimer&#146;s disease, and previous intellectual deficits that may confound the clinical diagnosis. There is a clear need to validate specific instruments adapted to Spanish population. Aim. To adapt and to validate CAMDEX-DS (Cambridge Examination for Mental Disorders of Older People with Down&#146;s Syndrome and Others with Intellectual Disabilities) in Spanish population. Patients and methods. 146 patients with intellectual disability (mild to moderate) were recruited and assessed with CAMDEX-DS, K-BIT I and DMR tests. Test-retest reliability, inter-rater concordance and validity statistic were performed between CAMDEX-DS and clinical diagnosis. This is an observational, multicenter, cross-sectional and validation study. Results. Test-retest and inter-rater reliability achieved kappa coefficient values of 0.92 and 0.91, respectively. Agreement (kappa index) for CAMDEX-DS on clinical diagnosis compared to other clinical criteria was high: CAMDEX-DS vs DSM-IV (kappa = 0.95; p &lt; 0,001); CAMDEX-DS vs ICD-10 (kappa = 0.97; p &lt; 0.001). All item-test correlations ranged between 0,31 and 0,69. Internal reliability-calculated using Chronbach&#146;s alpha scored 0.93.Conclusions. The Spanish version of CAMDEX-DS is a valid instrument with high applicability for people with intellectual disability. It shows good psychometric properties. The Cambridge Cognitive Examination for Older Adults with Down&#146;s Syndrome (CAMCOG-DS) can set two key points by the level of intellectual disability on the suspicion of cognitive impairment in people with Down&#146;s syndrome (AU)</dc:description>
<dc:creator>Novell Alsina, Ramón</dc:creator>
<dc:creator>García Alba, Javier</dc:creator>
<dc:creator>Vilá Alsina, Marta</dc:creator>
<dc:creator>Ribas Vidal, Nuria</dc:creator>
<dc:creator>Dalmau Bueno, Albert</dc:creator>
<dc:creator>Esteba Castillo, Susanna</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">síndrome de Down. Esta población presenta dos rasgos clínicos característicos: la presencia de demencia con semiología distinta a la enfermedad de Alzheimer típica y déficits intelectuales previos que pueden confundir el diagnóstico clínico. Existe una evidente necesidad de validar instrumentos específicos en castellano adaptados a esta población. Objetivo. Adaptar y validar el Cambridge Examination for Mental Disorders of Older People with Down&#146;s Syndrome and Others with Intellectual Disabilities (CAMDEX-DS) en población española. Pacientes y métodos. Se consideraron 146 pacientes con discapacidad intelectual (leve-moderada). Se realizó un estudio de validación de tipo observacional, transversal y multicéntrico. Se administraron los siguientes tests: CAMDEX-DS, testbreve de inteligencia de Kaufman y Dementia Questionnaire for Persons with Mental Retardation. Se calculó la fiabilidad test-retest, la fiabilidad interjueces, la concordancia del CAMDEX-DS para el diagnóstico clínico y la validez. Resultados. La fiabilidad test-retest e interjueces obtuvo un coeficiente kappa de 0,92 y 0,91, respectivamente. El índice kappa del CAMDEX-DS para el diagnóstico clínico respecto al resto de los criterios clínicos utilizados fue alto: CAMDEX-DS frente a DSM-IV (kappa = 0,95; p &lt; 0,001); CAMDEX-DS frente a Clasificación Internacional de Enfermedades, décima revisión (kappa = 0,97; p = 0,000). Todas las correlaciones ítem-test oscilaban entre 0,31 y 0,69. La fiabilidad interna calculada mediante el alfa de Cronbach fue de 0,93. Conclusiones. La versión española del CAMDEX-DS es un instrumento válido, de alta aplicabilidad a personas con discapacidad intelectual, que muestra buenas propiedades psicométricas. El Cambridge Cognitive Examination for Older Adults with Down&#146;s Syndrome (CAMCOG-DS) permite establecer dos puntos de corte para la sospecha de deterioro cognitivo en el grupo de personas con síndrome de Down en función del nivel de discapacidad intelectual previo (AU)</dc:description>
<dc:source>Rev Neurol;57(8): 337-346, oct. 2013. tab</dc:source>
<dc:identifier>ibc-116331</dc:identifier>
<dc:title xml:lang="es">Adaptación y validación del Cambridge Examination for Mental Disorders of Older People with Down&#146;s Syndrome and Others with Intellectual Disabilities (CAMDEX-DS) en población española con discapacidad intelectual</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d12031^s22039</dc:subject>
<dc:subject>^d30934</dc:subject>
<dc:subject>^d33554^s22083</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d545</dc:subject>
<dc:subject>^d9673</dc:subject>
<dc:subject>^d28575</dc:subject>
<dc:type>article</dc:type>
<dc:date>201310</dc:date>
</metadata>
</record>
</ibecs-document>
